Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun;33(2):195-201.
doi: 10.3803/EnM.2018.33.2.195.

Triennial Report of Endocrinology and Metabolism, 2015 to 2017

Editorial

Triennial Report of Endocrinology and Metabolism, 2015 to 2017

Eun Jung Rhee et al. Endocrinol Metab (Seoul). 2018 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. Number of manuscripts submitted during the period 2015 to 2017.
Fig. 2
Fig. 2. Final decision rate of submitted manuscripts (2015 to 2017).
Fig. 3
Fig. 3. Number of citations from the Web of Science Core Collection in 2013 to 2017.
Fig. 4
Fig. 4. Nations of authors citing Endocrinology and Metabolism (citations from 2015 to 2017).
Fig. 5
Fig. 5. Submissions by country of the submitting author (2015 to 2017).
Fig. 6
Fig. 6. Manuscripts accepted in 2015 to 2017 by country of the authors.
Fig. 7
Fig. 7. Categories of published manuscripts (2015 to 2017).

Similar articles

Cited by

References

    1. Lee WY. Endocrinology and Metabolism is indexed in the emerging sources citation index. Endocrinol Metab (Seoul) 2017;32:350–352. - PMC - PubMed
    1. Trimboli P, Giovanella L. Procalcitonin as marker of recurrent medullary thyroid carcinoma: a systematic review and meta-analysis. Endocrinol Metab (Seoul) 2018;22:204–210. - PMC - PubMed
    1. Hong N, Lee Y, Tsujita K, Gonzalez JA, Kramer CM, Kovarnik T, et al. Comparison of the effects of ezetimibe-statin combination therapy on major adverse cardiovascular events in patients with and without diabetes: a meta-analysis. Endocrinol Metab (Seoul) 2018;22:219–227. - PMC - PubMed
    1. Hyun KR, Kang S, Lee S. Cost-of-illness trends associated with thyroid disease in Korea. Endocrinol Metab (Seoul) 2014;29:257–269. - PMC - PubMed
    1. Sohn SY, Jang HW, Cho YY, Kim SW, Chung JH. Economic evaluation of recombinant human thyroid stimulating hormone stimulation vs. thyroid hormone withdrawal prior to radioiodine ablation for thyroid cancer: the Korean perspective. Endocrinol Metab (Seoul) 2015;30:531–542. - PMC - PubMed

Publication types

LinkOut - more resources